¶ … oral chlorhexidine as preventative agent in of ventilator-associated pneumonia (VAP) in adults who are critically ill and mechanically ventilated in intensive care units (ICUs). The process of critiquing published studies leads to higher level of comprehension of empirical and evidence-based research. The discussion devotes some consideration to the way the authors addressed the protection of human participants, the research methodology -- including data collection, data management and analysis -- the research findings, and the conclusions drawn from the study outcomes.
Protection of Human Participants
Risks to human participants in this research were minimal since the study is retrospective review of research. The original research studies protected the identity of the research participants, and data was presented in the aggregate form. The current research article is yet another layer away from the original studies and further still from the original information about the participants, none of which was presented in disaggregate form or with pertinent identifying features.
Data Collection
The research studies included in the review were randomized controlled trials (RCTs) published in English, and that used comparative groups to investigate the effect of oral chlorhexidine as a decontaminant in VAP prevention...
Omit Titles and Degrees] Klompas M., Speck, K., Howell M.D., Greene, L.R., & Berenholtz, S.M. (2014). Reappraisal of routine oral care with chlorohexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA internal medicine, 174 (5), 751-761. This article deals with the routine oral care of patients using chlorhexidine gluconate as standard care when they receive mechanical ventilation during their hospital stay. Their aim is to assess the overall
Introduction Advances in medicine have resulted in the further enhancement of patient outcomes in healthcare settings. It is, however, important to note that the treatment of many patients in close proximity does have some downsides. Hospital acquired infections (HAIs) are one such downside. In basic terms, HAIs are inclusive of all the infections that were not part of the original diagnosis of the patient during his or her admission at the
patients undergoing mechanical ventilation contract Ventilator Associated Pneumonia (VAP). This acute medical condition always results in increased death rates and associated medical costs among patients. This article reviews several literatures that try to enlighten masses on the diagnosis, medical treatments and VAP prevention methods. In addition, this article outlines recommendations medical practitioners can implement in their daily practices to curb VAP and offers an insight on controversies that usually
PICOT In critically ill adults (p), how does the daily use of chlorohexidine (I) compared to sterile water reduce VAP (ventilator-associated pneumonia) (O) during hospitalized stay (T). Part 2 Identifying a Problem Of the infections acquired by patients who've used mechanical ventilation in hospitals, ventilator-associated pneumonia is the most common. It causes several deaths, prolongs hospital stay and adds to the cost of medical care. Ventilator-associated pneumonia is commonly developed when pathogenic bacteria
pneumonia is a recurrent mechanical ventilation complication affecting almost 25% of ventilated patients. This type of pneumonia is referred to as ventilator-associated pneumonia (VAP) and it accounts for up to 90% of nosocomial infections among the 25% of ventilated patients, significantly increasing the cost, the duration of stay in the ICU, the duration of stay in the hospital and the length of stay under ventilation. The mortality rates for
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now